Edition:
United States

Medtronic PLC (MDT.N)

MDT.N on New York Stock Exchange

89.20USD
23 Jun 2017
Change (% chg)

-- (--)
Prev Close
$89.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,485,797
52-wk High
$89.58
52-wk Low
$69.35

MDT.N

Chart for MDT.N

About

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group,... (more)

Overall

Beta: 1.05
Market Cap(Mil.): $122,104.50
Shares Outstanding(Mil.): 1,368.89
Dividend: 0.46
Yield (%): 2.06

Financials

  MDT.N Industry Sector
P/E (TTM): 30.79 34.18 19.01
EPS (TTM): 2.90 -- --
ROI: 4.52 13.01 -5.03
ROE: 7.87 15.52 -4.28

BRIEF-Medtronic announces 7 pct increase in cash dividend

* Increases quarterly cash dividend by 7 percent to $0.46 per share

Jun 23 2017

BRIEF-Medtronic initiates U.S. launch of world's first hybrid closed loop system for type 1 diabetes​

* Medtronic Plc - ‍initiates u.s. Launch of world's first hybrid closed loop system for type 1 diabetes​ Source text for Eikon: Further company coverage:

Jun 07 2017

Medtronic's focus on surgical products fuels profit beat

Medtronic Plc 's fourth-quarter profit topped analysts' estimates as the world's largest standalone medical device maker saw increased demand across almost all of its businesses, including its minimally invasive therapies.

May 25 2017

UPDATE 3-Medtronic's focus on surgical products fuels profit beat

* Minimally invasive therapies unit sales up 6 pct (Adds details, analysts' comments)

May 25 2017

Medtronic reports 5.3 pct rise in quarterly profit

May 25 Medtronic Plc, the world's largest standalone medical device maker, reported a 5.3 percent rise in quarterly profit on Thursday, driven by higher sales in all of its businesses.

May 25 2017

BRIEF-QT Vascular updates on potential transaction with Medtronic

* Negotiations in relation to possible transaction(s) involving company's coronary product(s)

May 21 2017

LPC: U.S. merger lending bounces even as Trump agenda stalls

NEW YORK Mergers and takeovers by U.S. high-grade companies and billions of dollars of acquisition loans are ramping up after a sparse first quarter as corporations unwilling to wait for the Trump administration’s delayed tax, trade or healthcare reforms push the button on new deals.

May 18 2017

BRIEF-Medtronic Resolute Onyx 2.0 mm clinical study meets primary endpoint

* Medtronic resolute onyx(tm) 2.0 mm clinical study meets primary endpoint in extra-small vessels at one-year Source text for Eikon: Further company coverage:

May 18 2017

BRIEF-QT Vascular enters into asset purchase option agreement with Medtronic

* upon exercise of option by medtronic and closing , medtronic shall pay to sellers purchase consideration of us$28 million

May 11 2017

BRIEF-Medtronic receives FDA approval for MR-conditional quadripolar cardiac resynchronization therapy-pacemakers

* Medtronic first to receive FDA approval for MR-conditional quadripolar cardiac resynchronization therapy-pacemakers

May 10 2017

More From Around the Web

Earnings vs. Estimates